When it comes to the claims process, speed is of the utmost importance. However, too often, manual inefficient processes slow insurers down, resulting in settlement delays, a poor customer experience, and higher costs. And today’s economic climate only exacerbates claims leaders' challenges.
One of the main attributes of low-code development is speed. With the Appian Low-Code Platform, building, modifying and executing enterprise applications is fast and easy. And data is what powers those applications. That data has to be organized and managed, and this can slow down the development process.
With every iteration of automation technology that hits the market, one thing is clear: We are not far from a future where the only limit to what you can automate will be within the limits of your own imagination. Appian strives to open doors to the art of the possible by putting every automation capability you need to tackle any use case into our unified low-code platform. And in Appian 22.2, the latest product release, we’re opening Windows, too.
Here’s something to know about me. I love breakfast food. With a capital “L.” And I have for my whole life. So it’s kind of surprising that I only recently added a crepe pan to my collection of kitchen tools. This crepe pan is great. It’s non-stick, but made from all-natural materials, and it’s the perfect size. I could even use it to cook bacon. Or scramble eggs. But I won't.
As government agencies and organizations look to modernize their technology stacks to keep up with changes in the workforce, aging solutions, and closing contracts, they’ll all set out with a similar process: submit an RFP, review submissions, and choose a vendor. Seems simple enough. But what government CIOs often don’t realize is that requiring proven, specific use cases may be limiting what their new (and likely expensive) technology investment can do for their organization.
New breakthroughs in drug development are leading to groundbreaking results that could change lives in 2022 and beyond. However, at the dawn of a new decade, there are major challenges facing the industry that could prevent this innovation revolution. With the rising costs and increasing complexities involved in bringing products to market, life sciences organizations are re-examining their business operations and technology adoption.
